First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony.

PLoS Negl Trop Dis · 2009 · PMC2710502 · PMID 19636365

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The final outcome did not reach statistical significance in the intention-to-treat analysis, although the combination therapy did have a higher cure rate.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.